Monitor CURX for Nasdaq compliance confirmation after the split effective date. The reverse split does not change fundamentals; the stock's ability to maintain the $1.00 bid price depends on future operating performance and market conditions.
Price Chart
Executive Summary
Curanex Pharmaceuticals filed a Certificate of Amendment with the Nevada Secretary of State to effect a 1-for-20 reverse stock split, effective August 20, 2026, to regain compliance with Nasdaq's $1.00 minimum bid price requirement. The split reduces outstanding shares from ~31.4M to ~1.57M and is a routine capital structure adjustment with no change to authorized shares or par value. The filing is procedural and does not contain any new financial or operational information.
Key Facts
- 1-for-20 reverse stock split effective August 20, 2026.
- Outstanding shares reduced from ~31,364,812 to ~1,568,241.
- Authorized shares remain unchanged at 475,000,000.
- Purpose is to regain compliance with Nasdaq minimum bid price rule 5550(a)(2).
- No change to par value ($0.0001) or authorized preferred shares (25,000,000).
- Fractional shares rounded up to nearest whole share; no cash paid.
Financial Impact
No financial impact; reverse split is a mechanical share consolidation with no change to market cap or enterprise value.
Risk Factors
- Reverse splits often carry negative stigma and can lead to selling pressure.
- Failure to maintain bid price post-split could still result in delisting.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001493152-26-038764 |
| Document: 0001493152-26-038764-index-headers.html | 0001493152-26-038764 |
| Document: 0001493152-26-038764-index.html | 0001493152-26-038764 |
| Document: 0001493152-26-038764.txt | 0001493152-26-038764 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 19, 2026 7d ago | 8-K | $4.77 | awaiting T+20 | — | $4.60 (−3.46%) |
Aug 17, 2026 10w ago | 8-K | $4.44 $4.37 | ▼ −1.69% | ▼ −0.70% | $4.60 (+3.60%) |
May 14, 2026 23w ago | 8-K | $0.3130 $0.3210 | ▲ +2.56% | ▲ +3.41% | $4.60 (+1369.65%) |
May 14, 2026 23w ago | Press Release | $0.3130 $0.3210 | ▲ +2.56% | ▲ +3.41% | $4.60 (+1369.65%) |
May 7, 2026 24w ago | 8-K | $0.3160 $0.3260 | ▲ +3.16% | ▲ +0.03% | $4.60 (+1355.70%) |
Apr 2, 2026 29w ago | 8-K | $0.4900 $0.4170 | ▼ −14.90% | ▼ −24.77% | $4.60 (+838.78%) |
Mar 30, 2026 30w ago | Press Release | $0.5110 $0.4300 | ▼ −15.85% | ▼ −25.27% | $4.60 (+800.20%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers